Market Tracker

09/19 1:52pm ET

Immunomedics Inc (NASDAQ:IMMU)

3.23
Data as of 1:35pm ET
 -0.015 / -0.46%
Today’s Change
3.04
Today|||52-Week Range
7.35
-29.89%
Year-to-Date
No recent news for Immunomedics Inc.

Today’s Trading

Previous close3.24
Today’s open3.25
Day’s range3.19 - 3.28
Volume339,774
Average volume (3 months)471,968
Market cap$301.7M
Dividend yield--
Data as of 1:35pm ET, 09/19/2014

Growth & Valuation

Earnings growth (last year)-162.50%
Earnings growth (this year)-22.62%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+82.22%
P/E ratioNM
Price/Sales34.16
Price/Book7.66

Competitors

 Today’s
change
Today’s
% change
LMNSLumenis Ltd-0.02-0.22%
ARDXArdelyx Inc+0.23+1.74%
CLDNCelladon Corp-0.17-1.67%
IVCInvacare Corp+0.02+0.15%
Data as of 1:36pm ET, 09/19/2014

Financials

Next reporting dateNovember 6, 2014
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$9.0M
Annual profit (last year)-$35.4M
Net profit margin-391.81%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Medical Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts